دورية أكاديمية

Assessing cross-reactivity of Junín virus-directed neutralizing antibodies

التفاصيل البيبلوغرافية
العنوان: Assessing cross-reactivity of Junín virus-directed neutralizing antibodies
المؤلفون: Leske, Anne, Waßmann, Irke, Schnepel, Kevin, Shifflett, Kyle, Holzerland, Julia, Bostedt, Linus, Bohn, Patrick, Mettenleiter, Thomas C., Briggiler, Ana Maria, Brignone, Julia, Enria, Delia, Cordo, Sandra Myriam, Hoenen, Thomas, Groseth, Allison
بيانات النشر: Elsevier Science
المجموعة: CONICET Digital (Consejo Nacional de Investigaciones Científicas y Técnicas)
مصطلحات موضوعية: ANTIBODY CROSS-REACTIVITY, ARENAVIRUS, JUNÍN VIRUS, NEUTRALIZATION ASSAY, NEUTRALIZING ANTIBODIES, TRANSCRIPTION AND REPLICATION COMPETENT VIRUS-LIKE PARTICLE (TRVLP) ASSAY, https://purl.org/becyt/ford/1.6Test, https://purl.org/becyt/ford/1Test
الوصف: Arenaviruses cause several viral hemorrhagic fevers endemic to Africa and South America. The respective causative agents are classified as biosafety level (BSL) 4 pathogens. Unlike for most other BSL4 agents, for the New World arenavirus Junín virus (JUNV) both a highly effective vaccination (Candid#1) and a post-exposure treatment, based on convalescent plasma transfer, are available. In particular, neutralizing antibodies (nAbs) represent a key protective determinant in JUNV infection, which is supported by the correlation between successful passive antibody therapy and the levels of nAbs administered. Unfortunately, comparable resources for the management of other closely related arenavirus infections are not available. Given the significant challenges inherent in studying BSL4 pathogens, our goal was to first assess the suitability of a JUNV transcription and replication-competent virus-like particle (trVLP) system for measuring virus neutralization under BSL1/2 conditions. Indeed, we could show that infection with JUNV trVLPs is glycoprotein (GP) dependent, that trVLP input has a direct correlation to reporter readout, and that these trVLPs can be neutralized by human serum with kinetics similar to those obtained using authentic virus. These properties make trVLPs suitable for use as a proxy for virus in neutralization assays. Using this platform we then evaluated the potential of JUNV nAbs to cross-neutralize entry mediated by GPs from other arenaviruses using JUNV (strain Romero)-based trVLPs bearing GPs either from other JUNV strains, other closely related New World arenaviruses (e.g. Tacaribe, Machupo, Sabiá), or the distantly related Lassa virus. While nAbs against the JUNV vaccine strain are also active against a range of other JUNV strains, they appear to have little or no capacity to neutralize other arenavirus species, suggesting that therapy with whole plasma directed against another species is unlikely to be successful and that the targeted development of cross-specific monoclonal antibody-based ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
تدمد: 0166-3542
1872-9096
العلاقة: info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S0166354218305916Test; http://hdl.handle.net/11336/121808Test; Leske, Anne; Waßmann, Irke; Schnepel, Kevin; Shifflett, Kyle; Holzerland, Julia; et al.; Assessing cross-reactivity of Junín virus-directed neutralizing antibodies; Elsevier Science; Antiviral Research; 163; 3-2019; 106-116; CONICET Digital; CONICET
الإتاحة: https://doi.org/10.1016/j.antiviral.2019.01.006Test
http://hdl.handle.net/11336/121808Test
حقوق: info:eu-repo/semantics/restrictedAccess ; https://creativecommons.org/licenses/by-nc-sa/2.5/arTest/
رقم الانضمام: edsbas.CF20611A
قاعدة البيانات: BASE